Goldman Sachs’s Diebold Nixdorf Incorporated DBD Stock Holding History

Goldman Sachs’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-60,000	Closed	-$664K	–	5415
2019 Q1	$664K	Buy	60,000 +19,000	+46%	+$133K	﹤0.01%	4278
2018 Q4	$102K	Hold	41,000	–	–	﹤0.01%	4991
2018 Q3	$185K	Buy	+41,000	New	+$299K	﹤0.01%	4942
2013 Q3	–	Sell	-1,100	Closed	-$37K	–	6743
2013 Q2	$37K	Buy	+1,100	New	+$34K	﹤0.01%	6107

Other funds holding DBD

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

BFIM

Beese Fulmer Investment Management Canton, Ohio $1.56B AUM 26.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Goldman Sachs's DBD Position: Q2 2023 in Review

Goldman Sachs sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 295,173 shares — an estimated $354K sold.

Goldman Sachs first reported a position in DBD in Q2 2013 and held it in 40 quarters. The position peaked at $33.5M in Q2 2017. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

Goldman Sachs reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
Goldman Sachs sold 295,173 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $354K.
Goldman Sachs first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 40 quarters.
Goldman Sachs's Diebold Nixdorf Incorporated position peaked at $33.5M in Q2 2017.
7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.